A Phase II Study of Flavopiridol (HMR 1275; NSC 649890) in Patients With Previously Untreated Metastatic or Locally Advanced Soft Tissue Sarcoma.
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Alvocidib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Mar 2010 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 16 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.